603858
Buchang Pharma Unit Gets Nod to Market Fasudil Hydrochloride Injection Shandong Buchang Pharmaceuticals' (SHA:603858) unit, Tonghua Guhong Pharmaceutical, received a drug registration certificate from China's National Medical Products Administration for its fasudil hydrochloride injection, according to a Wednesday disclosure on the Shanghai Stock Exchange.The drug is used to prevent cerebral vasospasm and cerebral ischemia symptoms after surgery.The pharmaceutical company is allowed to market the drug until the expiry of the certificate's validation on Sept. 2, 2029.Price (RMB): ¥14.28, Change: ¥-0.050, Percent Change: -0.35%
时间：2024-09-11 12:55:15 市场： 美股 综合 A股